ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 219.60
+9.60 (4.57%)
Feb 27, 2026, 2:05 PM CET
ALK-Abelló Revenue
In the year 2025, ALK-Abelló had annual revenue of 6.31B DKK with 14.00% growth. ALK-Abelló had revenue of 1.73B in the quarter ending December 31, 2025, with 15.61% growth.
Revenue
6.31B
Revenue Growth
+14.00%
P/S Ratio
7.37
Revenue / Employee
2.42M
Employees
2,613
Market Cap
46.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.31B | 775.00M | 14.00% |
| Dec 31, 2024 | 5.54B | 713.00M | 14.78% |
| Dec 31, 2023 | 4.82B | 313.00M | 6.94% |
| Dec 31, 2022 | 4.51B | 595.00M | 15.19% |
| Dec 31, 2021 | 3.92B | 425.00M | 12.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| H. Lundbeck | 24.63B |
| Genmab | 23.66B |
| Demant | 22.97B |
| GN Store Nord | 16.78B |
| Zealand Pharma | 9.21B |
| Bavarian Nordic | 6.89B |
ALK-Abelló News
- 6 days ago - Alk-Abello AS (AKBLF) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus